Early detection through these simple tests can go a long way in preventing chronic kidney disease and the need for dialysis ...
Biocartis’ Idylla EGFR Mutation Test has secured the EU Technical Documentation Assessment and Quality Management System certificate, making it the first Idylla Test to achieve Class C companion ...
Mechelen, Belgium, 02 June 2025 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics company, is pleased to announce that its Idylla™ EGFR Mutation Test has received the European Union ...
Chronic kidney disease or CKD, is a condition that builds over time, as a result of inappropriate kidney function. The ...